ARTICLE | Finance
Warning: cash needed
Why biotechs may need to seek alternative financing options in 2019
January 12, 2019 1:03 AM UTC
A near decade-long run of cheap money appears to be coming to a close, and most of the biotech sector isn’t well positioned for the new reality.
BioCentury’s analysis shows that two-thirds of biotech companies could be facing a cash crunch in 2019 if the markets remain difficult. ...